Medtronic names Sally Saba its first Chief D&I Officer

0
1715
Sally Saba, Chief Inclusion and Diversity Officer, Medtronic

Medtronic, the global medical technology, services and solutions company, has hired Sally Saba for the newly created role of Chief Inclusion and Diversity Officer. Saba will assume the position next week, on 2nd March 2020.

In this role, she will be responsible for delivering a comprehensive global D&I strategy, to strengthen Medtronic’s inclusive culture and employment brand, ensuring the company is well-positioned to attract and retain top talent. Saba will report to Chief Human Resources Officer, Carol Surface.

“I am proud of the progress we’ve made, including our recent Catalyst recognition, and am excited to have Sally on board to continue to build on our strong foundation and help us reach new levels of inclusion, diversity, and equity at Medtronic,” said Surface. “Her thought leadership, authenticity and passion for the mission and healthcare make her uniquely suited to lead our efforts into the future.”

SHAPING THE FUTURE

Commenting on her new role, Saba stated: “My philosophy is to listen and learn, and bring people along to co-create. When employees participate in shaping the future of who they want to be as a company, they are more engaged, and we collectively move faster. Equity, inclusion and diversity isn’t one big thing you do – it’s a million little things that we all do every day.”

Most recently, Saba was the Vice President of Equity, Inclusion and Diversity at Kaiser Permanente Health Plan and Hospitals, the largest non-profit integrated healthcare system in America. During her time there, she spearheaded key initiatives, including a high-profile supplier diversity programme.

Before joining Kaiser, Saba served in leadership roles at global telecommunications company Vodafone. She holds a medical degree from Cairo University and an MBA from École Supérieure Libre des Sciences Commerciales Appliquées in Paris. 

Sign up for our newsletter

LEAVE A REPLY

Please enter your comment!
Please enter your name here